Stock Events

Stock Events

Claritas Pharmaceuticals 

$0.000100
2
+$0.00+0% Wednesday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
250
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

29MayExpected
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2015
2016
2017
2018
2019
2020
0Revenue
4.21MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a major player in the pharmaceutical industry, developing drugs that can compete directly with Claritas Pharmaceuticals' offerings.
Merck
MRK
Mkt Cap366B
Merck produces a wide range of pharmaceutical products that could compete in the same therapeutic areas as Claritas Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division, develops medications that may overlap with the treatments offered by Claritas Pharmaceuticals.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline focuses on a broad portfolio of drugs, potentially competing in the same niche as Claritas Pharmaceuticals.
Novartis
NVS
Mkt Cap292.35B
Novartis is known for its innovative medicines and could have competing products in the same categories as Claritas Pharmaceuticals.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in similar therapeutic areas and could have drugs that compete with those of Claritas Pharmaceuticals.
AMGEN
AMGN
Mkt Cap233.78B
Amgen, a biotech firm, develops therapies that might directly compete with Claritas Pharmaceuticals' biopharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb offers a range of prescription medicines that could directly compete with Claritas Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly and Company develops drugs that could be in direct competition with the treatments developed by Claritas Pharmaceuticals.
Sanofi
SNY
Mkt Cap107.39B
Sanofi produces a variety of pharmaceutical products that could compete across several of the same therapeutic areas as Claritas Pharmaceuticals.

About

Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Show more...
CEO
Robert Farrell
Employees
3
Country
Canada
ISIN
CA1806342061

Listings

STU
DE
S6V4.STU
OTC Link
US
CLAZF

0 Comments

Share your thoughts

FAQ

What is Claritas Pharmaceuticals stock price today?▼
The current price of CLAZF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Claritas Pharmaceuticals stock price performance more closely on the chart.
What is Claritas Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Claritas Pharmaceuticals stocks are traded under the ticker CLAZF.
Is Claritas Pharmaceuticals stock price growing?▼
CLAZF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Claritas Pharmaceuticals has showed a +0% increase.
What is Claritas Pharmaceuticals revenue for the last year?▼
Claritas Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Claritas Pharmaceuticals net income for the last year?▼
CLAZF net income for the last year is 4.21M USD.
How many employees does Claritas Pharmaceuticals have?▼
As of September 04, 2026, the company has 3 employees.
In which sector is Claritas Pharmaceuticals located?▼
Claritas Pharmaceuticals operates in the Health & Wellness sector.
When did Claritas Pharmaceuticals complete a stock split?▼
The last stock split for Claritas Pharmaceuticals was on July 23, 2021 with a ratio of 1:20.
Where is Claritas Pharmaceuticals headquartered?▼
Claritas Pharmaceuticals is headquartered in San Rafael, Canada.